The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes.
Studies of FcgammaRII-/- mice identified the inhibitory function of this receptor in joint inflammation and cartilage destruction induced with immune complexes (ICs). To extend our insight in the role of FcgammaRII in arthritis, we explored the role of FcgammaRII in the absence of activating receptors I and III using FcgammaRI/III-/- as well as FcgammaRI/II/III-/- mice. When antigen-induced arthritis (AIA) was elicited, which is a mixture of T cell and IC-driven inflammation, arthritis was almost absent at day 7 in FcgammaRI/III-/- mice. Remarkably, in FcgammaRI/II/III-/- mice, this model induced a tremendously increased arthritis as compared to wild-type controls. This implies that FcgammaRII regulates joint inflammation also in the absence of activating FcgammaRI and III. To confirm the IC specificity of this finding, similar studies were done with ICs or zymosan as arthritogenic stimuli. Strongly elevated inflammation was found in FcgammaRI/II/III-/- mice with IC but not with zymosan. Clearance studies identified accumulation of IgG in the knee joint in the absence of FcgammaRII. Moreover, macrophages expressing only FcgammaRII showed prominent endocytosis of preformed soluble ICs not different from controls. In total absence of FcgammaR (FcgammaRI/II/III-/-), macrophages completely failed to endocytose ICs. Although joint inflammation was much higher in AIA arthritic knee joints of FcgammaRI/II/III-/- and the inflammatory cells still expressed an inflammatory phenotype, severe cartilage destruction (MMP-mediated neoepitopes in the matrix and chondrocyte death) was completely prevented in contrast to the marked destruction which was observed in the wild-type. Our study indicates that FcgammaRII reduces joint inflammation in the absence of activating FcgammaR by promoting endocytosis and clearance of ICs from the joint. Infiltrating cells, which fail to express activating FcgammaR although they still become stimulated are no longer capable of inducing severe cartilage destruction.
van Lent
Peter
P
Department of Rheumatology, University Medical Centre St. Radboud, UMC Nijmegen Building 850, Geert grooteplein 26-28, Nijmegen, The Netherlands. P.vanlent@reuma.umcn.nl
Nabbe
Karin C
KC
Boross
Peter
P
Blom
Arjen B
AB
Roth
Johannes
J
Holthuysen
Astrid
A
Sloetjes
Annet
A
Verbeek
Sjef
S
van den Berg
Wim
W
D000818:Animals; D000936:Antigen-Antibody Complex / Q000378:metabolism*; D001169:Arthritis, Experimental / Q000139:chemically induced / Q000235:genetics / Q000473:pathology*; D002356:Cartilage / Q000473:pathology; D004705:Endocytosis; D007150:Immunohistochemistry; D007249:Inflammation / Q000235:genetics / Q000473:pathology; D007719:Knee Joint / Q000276:immunology / Q000473:pathology; D008264:Macrophages / Q000276:immunology / Q000378:metabolism; D051379:Mice; D017452:Receptors, IgG / Q000172:deficiency* / Q000235:genetics / Q000276:immunology*
D000936:Antigen-Antibody Complex; C499172:Fcgr2b protein, mouse; D017452:Receptors, IgG